The Wake Forest Institute for Regenerative Medicine invites applications for a postdoctoral fellowship position. The position is secured for two years with possibility of extension. The successful applicant will develop novel CRISPR/CAS9 delivery technology for gene therapy of genetic diseases. The lab has recently developed lentiviral capsid based CRISPR/CAS9 RNP delivery system and are developing other delivery methods for in vitro and in vivo applications. Please see our recent publications for our lentiviral capsid based delivery system:
Nucleic Acids Res. 2019 Sep 26;47(17):e99. doi: 10.1093/nar/gkz605.
Nucleic Acids Res. 2019 May 7;47(8):e44. doi: 10.1093/nar/gkz093.
The WFIRM provides a highly dynamic and collaborative environment to foster scientific breakthroughs. Applicants must have a recent Ph.D. in the field of cell biology or molecular medicine. The successful candidate should have demonstrated productivity in related fields and are motivated to take advantage of the vast resources available at Wake Forest Institute for Regenerative Medicine to do innovative research. Experience in one of the following areas is preferred: animal models, molecular biology and cellular biology. Previous experience with genome editing is a plus but not a prerequisite.
To apply, please send a CV, a cover letter describing your previous work and career goals, putative starting date and the contact information for three references to email@example.com.
Salary will be commensurate with relevant experience and based on the prevailing wage for postdoctoral research trainees set by the U.S. Department of Labor.